Haemonetics Corporation (HAE)
NYSE: HAE · Surgical & Medical Instruments & Apparatus · Boston, MA · filing with the SEC since 1996
Grade5.7
◀ Past 6.8● Present 6.5▶ Future 3.4
Filings
259 filings since 2017 beside 436 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-Q
Quarterly report for the quarter ending Jan 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by Mar 12, 2027
10-K
Annual report for the fiscal year ending Apr 3, 2027Large accelerated filers have 60 days after the fiscal year ends.
by Jun 2, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Jun 9, 2026.
Filings a yearinsider forms included
8771757172885949
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jul 28, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jul 28, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jul 24, 2026
40 of 259 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.